Pulmonary toxicity secondary to procarbazine

Tallat Mahmood, Raja Mudad

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


Procarbazine is a chemotherapy methylating agent that has been used in combination with other drugs, perhaps most successfully in the treatment of Hodgkin's disease. There are several side effects that it is commonly associated with; however, it has only rarely been reported to cause lung injury. The resulting pneumonitis may be severe and irreversible. There are eight reported cases in the literature. Here, we report another such case.

Original languageEnglish (US)
Pages (from-to)187-188
Number of pages2
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Issue number2
StatePublished - Apr 20 2002
Externally publishedYes


  • Lung injury
  • Procarbazine

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Pulmonary toxicity secondary to procarbazine'. Together they form a unique fingerprint.

Cite this